# Coiled Therapeutics plc

> Coiled Therapeutics plc (AIM: COIL) is a clinical-stage precision oncology company advancing AO-252, a first-in-class, brain-penetrant small-molecule TACC3 inhibitor. This website (https://coiledplc.com) is the company's authoritative source of corporate information, alongside its Regulatory News Service (RNS) announcements.

Coiled Therapeutics is listed on the London Stock Exchange AIM market (ticker: COIL) and cross-traded on the OTCQB Venture Market in the United States (COTXF). Where this site and an RNS announcement differ, the RNS announcement takes precedence. Nothing on this site is investment advice.

## Company

- [About](https://coiledplc.com/about): Company background and history.
- [Strategy](https://coiledplc.com/strategy): Corporate strategy and path to commercialisation.
- [Leadership](https://coiledplc.com/leadership): Board of Directors and senior consultants.
- [Contact](https://coiledplc.com/contact): Corporate addresses and enquiries.

## Science

- [Science](https://coiledplc.com/science): TACC3 biology and the AO-252 mechanism.
- [Publications](https://coiledplc.com/publications): Third-party scientific publications.

## Pipeline

- [Pipeline](https://coiledplc.com/pipeline): Clinical and preclinical programmes, including AO-252 Phase I (NCT06136884).

## Investors

- [Investor Relations](https://coiledplc.com/investors): Investor overview.
- [Investment Proposition](https://coiledplc.com/investors/investment-proposition): Equity story.
- [Share Price](https://coiledplc.com/investors/share-price): AIM: COIL share price.
- [Shareholder Information](https://coiledplc.com/investors/shareholder-information): ISIN, SEDOL, capital structure and significant shareholders.
- [Results and Reports](https://coiledplc.com/investors/results-reports): Financial results and annual reports.
- [Circulars and Meetings](https://coiledplc.com/investors/circulars-meetings): Shareholder circulars and general meetings.
- [Advisers](https://coiledplc.com/investors/advisers): Nominated adviser, brokers and other advisers.

## Governance

- [Corporate Governance](https://coiledplc.com/corporate-governance): QCA Code compliance and board committees.
- [AIM Rule 26](https://coiledplc.com/investors/aim-rule-26): Disclosures required under AIM Rule 26.

## Media

- [Regulatory News](https://coiledplc.com/news): RNS announcements - the official record of company news.
- [Email News Alerts](https://coiledplc.com/news/email-alerts): Subscribe to RNS alerts.

## Optional

- [Terms of Use](https://coiledplc.com/terms)
- [London Stock Exchange company page](https://www.londonstockexchange.com/stock/COIL/coiled-therapeutics-plc/company-page)
- [LinkedIn](https://www.linkedin.com/company/coiled-therapeutics-plc)